Boston Advisors’s PetMed Express PETS Stock Holding History

Boston Advisors’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-21,530	Closed	-$948K	–	668
2018 Q2	$948K	Buy	+21,530	New	+$834K	0.02%	386

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Boston Advisors's PETS Position: Q3 2018 in Review

Boston Advisors sold out of PetMed Express (PETS) in Q3 2018, closing a stake of 21,530 shares — an estimated $948K sold.

Boston Advisors first reported a position in PETS in Q2 2018 and held it in 1 quarter. The position peaked at $948K in Q2 2018. 199 funds tracked by Wall St. Rank hold PETS as of Q3 2018.

Boston Advisors reported no remaining PetMed Express position as of Q3 2018 after selling out during the quarter.
Boston Advisors sold 21,530 PetMed Express shares in Q3 2018, an estimated $948K.
Boston Advisors first reported a position in PetMed Express in Q2 2018 and held it in 1 quarter.
Boston Advisors's PetMed Express position peaked at $948K in Q2 2018.
199 funds tracked by Wall St. Rank held PetMed Express as of Q3 2018.

Based on Boston Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.